Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2022-04-11 Share Issue/Capital Cha…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
PR 11042022 - FR.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and is dated April 11, 2022, marked as "Information réglementée" (Regulated Information). The content details transactions where UCB SA alienated (sold/transferred) its own shares following the exercise of options by employees under various Long-Term Incentive (LTI) plans. This directly relates to the company managing its own share capital, specifically through transactions involving its treasury stock or issuance related to employee compensation plans. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance, including transactions related to employee stock plans. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific regulatory disclosure about share transactions.
2022-04-11 French
PR 11042022 - NL.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were delivered to employees as part of long-term incentive plans (stock options and vesting). This involves the company dealing in its own shares. The content explicitly reports on the number of shares transacted, the dates, and the context (LTI plans). This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities by the company itself. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a Director's Dealing (DIRS) as it concerns employee incentive plans rather than personal trades by directors/executives.
2022-04-11 Dutch
PR ENG 01.04.22.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "Disposal of own shares" and details transactions where UCB disposed of its own shares OTC following the exercise of stock options by personnel under various Long-Term Incentive (LTI) Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Reviewing the filing definitions, 'Transaction in Own Shares (Code: POS)' is the most appropriate category, as it covers the company buying back or selling its own shares. The document is a formal press release dated April 1, 2022, detailing transactions that occurred in late March 2022. It is not a general announcement of a report (RPA) or a miscellaneous filing (RNS), but a specific disclosure about share transactions.
2022-04-01 English
PR FR 01.04.22.pdf
Transaction in Own Shares Classification · 100% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and it details transactions where the company (UCB SA) disposed of its own shares following the exercise of options by employees as part of long-term incentive plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification. The document is a formal announcement dated April 1, 2022, providing specific transaction details.
2022-04-01 French
PR NL 01.04.22.pdf
Transaction in Own Shares Classification · 98% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB shares were transferred (disposed of) to employees as part of long-term incentive plans (stock options). This directly relates to the company buying back or issuing its own shares, specifically in the context of employee share schemes. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement dated April 1, 2022, detailing transactions that occurred between March 25 and March 31, 2022, and it is explicitly labeled as 'Gereglementeerde informatie' (Regulated information). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific transaction report.
2022-04-01 Dutch
220325 - Disposals of own shares_ENG.pdf
Director's Dealing Classification · 99% confidence The document is explicitly titled "Disposal of own shares" and details numerous transactions where UCB disposed of its own shares OTC following the exercise of stock options by personnel under various LTI Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches the definition for Transaction in Own Shares (POS). The document is a formal press release announcing these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive data itself.
2022-03-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.